Recently, researchers at Yale University and the University of Connecticut collaborated to develop a nanoparticle-based treatment to fight glioblastoma (GBM), one of the most harmful malignancies with a high recurrence rate and poor clinical outcome. This newly developed technique targets multiple factors associated with GBM progression and invasiveness. The findings were published in Science Advances.
GBM: Cause and Conventional Treatment
Around 14.5% of nervous system tumors have been linked to GBM, with a survival rate of approximately 15 months. The incidence rate of GBM in the US is 4.32 per 100,000 persons a year, with a poor survival rate.
Conventional treatment of GBM includes surgery, followed by radio-and-chemo-therapy. Notably, temozolomide (TMZ), a chemotherapy treatment in combination with radiotherapy has improved survival rate by two years.
MicroRNAs (miRNAs) are approximately 25 nucleotides long non-coding RNAs involved with genetic expressions at the post-transcriptional level. Several studies have indicated that miRNA dysregulation, at an up-regulation (oncomiRNAs) or down-regulation, is a potential driver of malignancies.
Unusual miRNA expression levels were observed in patients with GBM, which resulted in poor prognosis and survival rates. For instance, miR-10b and miR-21 were identified to be the significantly up-regulated oncomiRs, manifesting GBM.
Mechanistically, miR-10b increases GBM growth by negatively regulating transcription factor AP-2γ (TFAP2C), cyclin-dependent kinase inhibitor I (p21) expression, BCL2 interacting mediator of death (Bim), and tumor suppressor cyclin-dependent kinase 2A inhibitor (CDKN2A/16). Similarly, GBM invasiveness is increased by up-regulated miR-21 levels.
Mechanistically, an up-regulated miR-21 inhibits matrix metalloproteinase (MMP) and stimulates cell proliferation via negative regulation of phosphatase and tensin homolog (PTEN) and insulin-like growth factor–binding protein-3 (IGFBP3). It also induces tumor stemness through SRY-box transcription factor-2 (SOX-2).
In vivo experiments revealed that miR-10b inhibition reduces intracranial GBM tumor growth, which ultimately prompted the development of antisense oligonucleotide (RGLS5799, Regulus Therapeutics) targeting miR-10b.
Alternatively, knocking down miR-21 decreases GBM advancement and invasion. This treatment also reduces GBM cell’s chemoresistance to TMZ and taxol. The available GBM therapeutics mainly target a single oncomiR, which has shown reduced efficacy.
A New Nano-based GBM Treatment
As stated above, scientists from Yale and the University of Connecticut have designed a nanoparticle-based treatment for GBM. This therapy targets both miRNAs, i.e., miR-10b and miR-21 simultaneously, to increase the chemosensitization of GBM toward TMZ.
In this study, bioadhesive nanoparticles were used, which contained newly synthesized peptide nucleic acids (PNAs). PNAs were able to actively regulate gene expression, particularly oncomiRs. They are synthetic nucleic acid analogs, in which the phosphodiester backbone is replaced with neutral N-(2-aminoethyl) glycine units. The newly developed bioadhesive nanoparticles adhere to the tumor site, slowly release the PNAs that target oncomiRNAs, and inhibit tumor-promoting activity.
Typically, PNAs bind to targeted miRNAs via a complementary DNA base pairing system, and this structure is enzymatically stable. However, compared to classical PNAs, serine-gamma PNAs (γPNAs), with specific modification at the γ position, exhibit superior binding affinity, physicochemical features, and specificity. Previous studies have also indicated that anti-seed sγPNAs are clinically more translatable with minimal toxicity.
The newly designed γPNAs are complementary to the seed region of oncomiR-21 and oncomiR-10b, to improve anti-miRNA activity. Besides its simplistic synthesis methodology, γPNAs are also ideal for conjugation with fluorophores or other probes, which are useful for imaging.
The convection-enhanced delivery (CED) system has been developed to directly introduce polymeric nanoparticles (NPs) loaded with active agents to brain tumors. In this study, the bioadhesive NPs (BNPs) comprised hyperbranched polyglycerol (PLA-HPG) and a copolymer of poly(lactic acid), ultimately forming PLA-HPG-CHO, which is highly beneficial to deliver PNA anti-miRs.
In this study, PLA-HPG-CHO BNPs were loaded with two sγPNAs, one bound to miR-10b and the other to miR-21. The Gel shift assays showed the binding of the synthesized sγPNAs (sγPNA-21 and sγPNA-10b) with the respective miR. This finding indicated that the newly designed sγPNAs were highly specific and had a strong affinity for target oncomiRs.
Compared to classical PNAs loaded in the PLA-HPG-CHO BNPs, sγPNAs loaded in PLA-HPG-CHO BNPs exhibited a greater miR inhibition. When sγPNAs loaded PLA-HPG-CHO BNPs were evaluated in a GBM challenged mice model, the treated mice lived longer compared to the control mice.
Notably, sγPNAs loaded PLA-HPG-CHO BNPs remained at the target site for about 40 days, which is extremely advantageous compared to conventional site-specific treatments that wane off fairly quickly.
In addition, as the current treatment knocks down both GBM targets simultaneously, it is more powerful than existing treatments. Mark Saltzman, a professor at the Yale Cancer Center, who was involved with this research, stated, “These results are the best I’ve ever seen in this sort of aggressive brain tumor.”

News
Repurposed drugs could calm the immune system’s response to nanomedicine
An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in cancer and vaccine treatments, [...]
Nano-Enhanced Hydrogel Strategies for Cartilage Repair
A recent article in Engineering describes the development of a protein-based nanocomposite hydrogel designed to deliver two therapeutic agents—dexamethasone (Dex) and kartogenin (KGN)—to support cartilage repair. The hydrogel is engineered to modulate immune responses and promote [...]
New Cancer Drug Blocks Tumors Without Debilitating Side Effects
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI. A new cancer drug candidate, developed through a collaboration between Lawrence Livermore National Laboratory (LLNL), BridgeBio Oncology [...]
Scientists Are Pretty Close to Replicating the First Thing That Ever Lived
For 400 million years, a leading hypothesis claims, Earth was an “RNA World,” meaning that life must’ve first replicated from RNA before the arrival of proteins and DNA. Unfortunately, scientists have failed to find [...]
Why ‘Peniaphobia’ Is Exploding Among Young People (And Why We Should Be Concerned)
An insidious illness is taking hold among a growing proportion of young people. Little known to the general public, peniaphobia—the fear of becoming poor—is gaining ground among teens and young adults. Discover the causes [...]
Team finds flawed data in recent study relevant to coronavirus antiviral development
The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-CoV-2's molecular structure known as the NiRAN domain—an [...]
Drug-Coated Neural Implants Reduce Immune Rejection
Summary: A new study shows that coating neural prosthetic implants with the anti-inflammatory drug dexamethasone helps reduce the body’s immune response and scar tissue formation. This strategy enhances the long-term performance and stability of electrodes [...]
Scientists discover cancer-fighting bacteria that ‘soak up’ forever chemicals in the body
A family of healthy bacteria may help 'soak up' toxic forever chemicals in the body, warding off their cancerous effects. Forever chemicals, also known as PFAS (per- and polyfluoroalkyl substances), are toxic chemicals that [...]
Johns Hopkins Researchers Uncover a New Way To Kill Cancer Cells
A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically unstable tumors. Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Radiation Oncology and Molecular [...]
AI matches doctors in mapping lung tumors for radiation therapy
In radiation therapy, precision can save lives. Oncologists must carefully map the size and location of a tumor before delivering high-dose radiation to destroy cancer cells while sparing healthy tissue. But this process, called [...]
Scientists Finally “See” Key Protein That Controls Inflammation
Researchers used advanced microscopy to uncover important protein structures. For the first time, two important protein structures in the human body are being visualized, thanks in part to cutting-edge technology at the University of [...]
AI tool detects 9 types of dementia from a single brain scan
Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, using a single, widely available scan—a transformative [...]
Is plastic packaging putting more than just food on your plate?
New research reveals that common food packaging and utensils can shed microscopic plastics into our food, prompting urgent calls for stricter testing and updated regulations to protect public health. Beyond microplastics: The analysis intentionally [...]
Aging Spreads Through the Bloodstream
Summary: New research reveals that aging isn’t just a local cellular process—it can spread throughout the body via the bloodstream. A redox-sensitive protein called ReHMGB1, secreted by senescent cells, was found to trigger aging features [...]
AI and nanomedicine find rare biomarkers for prostrate cancer and atherosclerosis
Imagine a stadium packed with 75,000 fans, all wearing green and white jerseys—except one person in a solid green shirt. Finding that person would be tough. That's how hard it is for scientists to [...]
Are Pesticides Breeding the Next Pandemic? Experts Warn of Fungal Superbugs
Fungicides used in agriculture have been linked to an increase in resistance to antifungal drugs in both humans and animals. Fungal infections are on the rise, and two UC Davis infectious disease experts, Dr. George Thompson [...]